Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS-8958 Phase 3 study in Pediatric Patients < 10 years of age
jRCT2080223343Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of laninamivir in Influenza A infection and influenza B, sponsored by Daiichi Sankyo Co., Ltd. Started Oct 2016; status: completed.
02
Drugs
laninamivir
03
Conditions
Influenza A infectioninfluenza B
Beyond the preview
Go deeper on jRCT2080223343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223343.